Cerebral President and CMO David Mou, MD, Named Chief Executive Officer as CEO Kyle Robertson Leaves Position

Chief Operating Officer Jessica Muse Assumes President Role for Company, Clinical Advisor Thomas Insel agrees to join Board SAN FRANCISCO–(BUSINESS WIRE)–#Cerebral–David Mou, MD MBA, the company’s President and Chief Medical Officer, has been named as Cerebral’s Chief Executive Officer. Cofounder Kyle Robertson leaves his position as CEO, effective immediately. “We thank Kyle for his service. … [Read more…]

CHD Files Comments with FCC Urging Accommodation of Millions of People Sickened by Wireless Radiation

WASHINGTON–(BUSINESS WIRE)–On May 16, Children’s Health Defense (CHD) and 50 other safe tech and health advocacy non-profits filed legal comments with the Federal Communications Commission (FCC) in response to the FCC’s request for comment on how to “prevent and eliminate digital discrimination.” The proceeding was required by the Infrastructure Investment and Jobs Act (“Infrastructure Act”) … [Read more…]

Global $10.84 Bn Antacids Markets, Analysis, & Forecasts 2016-2021, 2021-2026F, 2031F by Drug Class, Distribution Channel, Formulation Type – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antacids Global Market Report 2022, By Drug Class, Distribution Channel, Formulation Type” report has been added to ResearchAndMarkets.com’s offering. The global antacids market is expected to grow from $8.60 billion in 2021 to $9.13 billion in 2022 at a compound annual growth rate (CAGR) of 6.1%. The market is expected to reach $10.84 … [Read more…]

Global Osteoporosis Drugs Market Report (2022 to 2027) – Featuring GlaxoSmithKline, Novartis International and Merck & Co Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Osteoporosis Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering. This latest research report provides a detailed analysis of Osteoporosis Drugs Industry. The global osteoporosis drugs market is projected to reach $16.43 Billion in 2027, from $12.01 Billion in 2021. … [Read more…]

Global Biologics Market Report 2022: A $540.66 Billion Market in 2026 – Leading Products & Services, Key Features & Differentiators, and Development Products – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biologics Global Market Report 2022: By Type, By Distribution, By Route, By Drug, By Mode” report has been added to ResearchAndMarkets.com’s offering. The global biologics market is expected to grow from $338.45 billion in 2021 to $382.04 billion in 2022 at a compound annual growth rate (CAGR) of 12.9%. The market is expected … [Read more…]

Global $129+ Bn Cancer Biologics Market Research, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cancer biologics Global Market Report 2022: By Type, By Application, By Distribution” report has been added to ResearchAndMarkets.com’s offering. The global cancer biologics market is expected to grow from $76.46 billion in 2021 to $86.64 billion in 2022 at a compound annual growth rate (CAGR) of 13.3%. The market is expected to reach … [Read more…]

AdaptHealth to Participate in UBS Global Healthcare Conference 2022

PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President and Director, and Jason Clemens, CFO, will participate in a fireside chat at the UBS Global Healthcare Conference 2022 on Wednesday, … [Read more…]

Research Confirms Patients with Essential Tremor and Parkinson’s Disease Have Higher Comorbidities and Costs

Real-world claims data connects patients with essential tremor and Parkinson’s disease with a higher prevalence of comorbidities, including psychiatric disorders, a greater number of falls, and rates of substance abuse SAN MATEO, Calif.–(BUSINESS WIRE)–Cala Health, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced new clinical research presented … [Read more…]

Voices Urging Action on Antimicrobial Resistance Take to Capitol Hill

Congressional leaders honored for supporting legislative action to #SquashSuperbugs WASHINGTON–(BUSINESS WIRE)–#AMR–Today the Partnership to Fight Infectious Disease (PFID), along with the Infectious Diseases Society of America (IDSA), Boomer Esiason Foundation and the Cystic Fibrosis Foundation, unite to highlight the urgency for action on antimicrobial resistance (AMR). An estimated 2.8 million antibiotic-resistant infections occur in the … [Read more…]

United States Respiratory Protective Equipment Market Report 2022: Air-purifying Respirators & Supplied Air Respirators – Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “United States Respiratory Protective Equipment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering. The report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that are driving and restraining the respiratory protective … [Read more…]